Ozempic Lawsuit 2025: Ozempic is currently facing over 1,800 lawsuits in US courts almost costing it $2 billion. Patients claim that the side effects are severe and that they have not been warned of the same.A recent study published in JAMA noted of the Ozempic Vision, where this popular weight loss drug caused vision loss to many. Now, it is Ozempic stomach, or stomach paralysis. These lawsuits has put the liability on Novo Nordisk and the claims could even cross the $2 billion mark. This, could in fact, become one of the costliest drug safety dispute in the history. What Is Ozempic?It is a once-weekly injectable medication that must be used along side diet and exercise to manage type 2 diabetes. It has been approves by the US Food and Drug Administration (FDA), and is also said to reduce risk of major heart-related events, worsening kidney disease, and helping with weight loss. This belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist drug class.Also Read: Popular Weight Loss Drugs Could Be Linked To Vision Loss, Finds New StudyThe Ozempic 'Stomach': Stomach ParalysisRecent research have indicated a link between Ozempic and stomach paralysis or gastroparesis or bowel injury. However, here, 'paralysis' does not mean the stomach is permanently inactive, instead, it means that the medication slows stomach emptying and some people can be more affected than others. A study analyzing FDA safety data from 2018 to early 2022 identified 48 such cases of stomach paralysis, out of which, 26 were serious and 22 were non serious. This data was collected among the 5,442 reported of semaglutide-related gastrointestinal issues.Also Read: Ozempic Vulva To Ozempic Smell – Unexpected Ways Of Weight Loss Jabs Change Your Body Symptoms of Ozempic StomachStomach discomfortBloatingFeeling full too early after you start eating a mealNauseaWhy Does Ozempic Stomach Happen?Ozempic (semaglutide) mimics the hormone GLP-1, helping lower blood sugar and reduce appetite by slowing gastric emptying and gut movement. While effective for diabetes and weight loss, in some people it can delay digestion, causing food build-up (bezoars), nausea, and in rare cases, stomach or intestinal paralysis.As per a 2024 study published in Cureus, titled: Tendency of Semaglutide to Induce Gastroparesis: A Case Report, notes of a case study of a 53-year-old woman who had a medical history of depression, obesity stage 2 and obstructive sleep apnea. She was also presented to the hospital due to nausea and abdominal pain, which lasted for three weeks.The woman had been on a .5mg of semglutide injection weekly, for proceeding four months of her weight loss. She lost about 40 pounds during this period and did not increase her dose of semaglutide. Her esophagogastroduodenoscopy (EGD) showed small volume of retained semisolid food material and liquid in the cardia, while she had been on a liquid diet for 24 hours.Also Read: ‘Ozempic Vulva’: The Bizarre Side Effect Affecting Women’s Health This finding of retained food was considered highly consistent with the diagnosis of gastroparesis. It indicated that despite the liquid diet, she had solid food remains, which means her stomach is not emptying the way it should. The woman was recommended to stop using semaglutide, and as a result, she reported "significant improvement in symptoms at one-month follow-up after stopping semaglutide, with complete resolution of nausea".
Email
Google
Facebook Email Google Facebook